Market Cap (In TWD)
1.48 Billion
Revenue (In TWD)
333.85 Million
Net Income (In TWD)
11.67 Million
Avg. Volume
3014.00
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 48.4-93.9
- PE
- -
- EPS
- -
- Beta Value
- 0.195
- ISIN
- TW0006879000
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- -
- Employee Count
- -
- Website
- https://www.genext.me
- Ipo Date
- 2022-05-26
- Details
- TCI GENE Inc. provides precision preventive medicines in Taiwan. It offers genetic testing for nutrient metabolism and weight management; G2 and ACE2 genetic testing; supplements; skin care, antiaging, kids' growth, and Alzheimer disease products; and serum for DNA types. The company also provides nutrition consultation services. TCI GENE Inc. is based in Taipei, Taiwan.
More Stocks
-
0A60
-
QATI
-
AGF-BAGF A/S
AGF-B
-
SMAR
-
CIFL
-
7575
-
S
-
603329